The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1292
August 11, 2008
View Complete Issue         Table of Contents 2019 
Antiplatelet Therapy for Patients with Stents
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Antiplatelet Therapy for Patients with Stents
August 11, 2008 (Issue: 1292)
The antiplatelet agents aspirin and clopidogrel (Plavix, and others) are used in most patients undergoing percutaneous coronary intervention (PCI) to prevent stent thrombosis and to reduce the occurrence of peri-, post-procedural and late...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Antiplatelet Therapy for Patients with Stents
Article code: 1292a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.